News and Headlines

Actions

Purdue researchers reveal Zika virus structure

Posted
and last updated

WEST LAFAYETTE, Ind. -- A team led by Purdue University has determined the structure of the Zika virus, revealing important information to the development of effective treatments and vaccines. 

Researchers announced the news Thursday. 

The team of researchers also identified regions within the Zika virus structure where it differs from other flaviviruses, the family of viruses to which Zika belongs that includes dengue, West Nile, yellow fever, Japanese encephalitis and tick-borne encephalitic viruses.

Any regions within the virus structure unique to Zika have the potential to explain differences in how a virus is transmitted and how it manifests a disease, Richard Kuhn, director for the Purdue Institute for Inflammation, Immunology and Infectious Diseases said in a press release from Purdue University. 

RELATED | Indiana State Department of Health confirms first case of Zika virus | Zika virus linked to growing list of complications | CDC: Men who were in Zika areas should use condoms | Higher temperatures make Zika mosquito spread disease more | CDC: Travel OK to high-elevation cities in Zika countries | Study: 1st evidence that Zika may cause temporary paralysis | CDC expands range of Zika mosquito into parts of Northeast

"The structure of the virus provides a map that shows potential regions of the virus that could be targeted by a therapeutic treatment, used to create an effective vaccine or to improve our ability to diagnose and distinguish Zika infection from that of other related viruses," Kuhn said.

"This breakthrough illustrates not only the importance of basic research to the betterment of human health, but also its nimbleness in quickly addressing a pressing global concern. This talented team of researchers solved a very difficult puzzle in a remarkably short period of time, and have provided those working on developing vaccines and treatments to stop this virus a map to guide their way," Purdue President Mitch Daniels said. 

The team plans to continue testing to evaluate the different regions as targets for treatment and to develop potential therapeutic molecules.

--------------

Download the new and improved RTV6 app to get the latest news on the go and receive alerts to your phone

Sign up to have the latest news headlines delivered straight to your email inbox